Obstetrics

Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile

Retrieved on: 
星期三, 三月 13, 2024
Principal, Pregnancy, Sheba Medical Center, Growth, COVID-19, Patient, Prenatal care, Michigan Medicine, Transport, University, Telehealth, MD, Trial of the century, Gynaecology, Safety, BPP, Marketing, Movement, Obstetrics, Medical imaging

The study will examine the ability to conduct a remote biophysical profile (BPP) test, by using the Pulsenmore home ultrasound with the guidance of a remote clinician, potentially reducing the clinical burden.

Key Points: 
  • The study will examine the ability to conduct a remote biophysical profile (BPP) test, by using the Pulsenmore home ultrasound with the guidance of a remote clinician, potentially reducing the clinical burden.
  • The Pulsenmore prenatal home ultrasound, empowers pregnant women to connect their personal smartphones to a dedicated device and application, allowing them to perform ultrasound imaging scans from the comfort of their homes.
  • These scans are seamlessly transmitted to the hospital for evaluation, focusing on essential fetal vitality parameters.
  • The company continues to expand its operations by growing its' distribution and collaborations with health organizations in key markets.

Cepheid Receives FDA Clearance for Xpert® Xpress GBS

Retrieved on: 
星期一, 三月 11, 2024
PCR, Obstetrics, Streptococcus, Rheumatic fever, EVP, INT, Risk, Cepheid variable, Antibiotic prophylaxis, Antimicrobial stewardship, Fungal infection, Genome, Woman, American College, GBS, Negative, ACOG, Infant, Food, Sintering

SUNNYVALE, Calif., March 11, 2024 /PRNewswire/ -- Cepheid announced today that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of Group B Streptococcus (GBS). This next-generation test incorporates new dual targets in highly-conserved regions of the GBS genome to improve sensitivity and bacterial strain coverage. The test is designed for use on Cepheid's GeneXpert® systems.

Key Points: 
  • SUNNYVALE, Calif., March 11, 2024 /PRNewswire/ -- Cepheid announced today that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of Group B Streptococcus (GBS).
  • Xpert Xpress GBS allows for the use of intrapartum direct PCR testing for women with unknown or unavailable antepartum GBS status.
  • With the capability of returning positive results as early as 30 minutes,2 Xpert Xpress GBS can provide real-time GBS status and inform decisions about empiric antibiotic prophylaxis if appropriate, to prevent GBS transmission during birth.
  • With Xpert Xpress GBS, Cepheid continues to provide fast, accurate, and reliable PCR solutions to facilitate evidence-based treatment and improved clinical care.

Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024

Retrieved on: 
星期三, 三月 6, 2024
BSN, RN, HIMSS, EST, MBA, Northwell Health, Associate, MPH, Automation, Obstetrics, Nursing

Boston, March 06, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, is attending HIMSS 2024 , March 11-15, in Orlando, Fla. Company leaders will be in booth #1441 to discuss Amwell’s hybrid care enablement platform, Virtual Nursing solution, automated care and behavioral health programs and how this technology can address workforce shortages, access to care, the mental health crisis and other industry challenges.

Key Points: 
  • Boston, March 06, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, is attending HIMSS 2024 , March 11-15, in Orlando, Fla. Company leaders will be in booth #1441 to discuss Amwell’s hybrid care enablement platform, Virtual Nursing solution, automated care and behavioral health programs and how this technology can address workforce shortages, access to care, the mental health crisis and other industry challenges.
  • Northern Light Health uses the Amwell ConvergeTM platform, integrated with its electronic health record, as well as Amwell hardware devices, to support a variety of programs designed to improve patient and provider experiences.
  • El Camino Health and Northwell Health use Amwell Automated Care Programs to provide chat-based virtual companions for post-discharge, pre- and post-surgery, chronic conditions, obstetrics and more.
  • For more information about Amwell at HIMSS, or to talk with a company leader during the event, contact [email protected] .

Ovation Fertility Welcomes Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), as Cincinnati Lab Director

Retrieved on: 
星期二, 二月 20, 2024
Gynaecology, OBGYN, Doctor of Philosophy, Suite, Research, Physician, Wright, IVF, ELD, ABB, Cryopreservation, Andrology, Obstetrics, University, Jan Vansina, Patient, FIRST, Knowledge, Diagnosis, Laboratory, Partnership, Medical device

Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.

Key Points: 
  • Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.
  • Dr. Warikoo comes to Ovation from the Bethesda Fertility Center Reproductive Study Lab in Cincinnati, where he has served as scientific director for more than 25 years.
  • “Ovation’s expansion in the Cincinnati area involves a close partnership with our partner physicians at the Institute for Reproductive Health, which combined with Bethesda Fertility Center effective February 1,” says Conor Beardsley, President of Ovation Fertility.
  • He is board certified by the American Board of Bioanalysis as a High Complexity Laboratory Director, Embryology Laboratory Director and Clinical Consultant.

Hope for Women: Womed Unveils First Fertility Restoration Device Proven Effective in Randomized Clinical Trial

Retrieved on: 
星期四, 三月 7, 2024
Research, Medical Devices, Women, Baby, Maternity, Clinical Trials, Health Technology, Biotechnology, Consumer, Health, Science, Hospital, Choix, Woman, Recurrence, Vaginal discharge, Multimedia, News, Uterus, Pain, Female, Safety, Obstetrics, Patient, Knowledge, Curettage, Infertility, IUA, Birth control

No device indicated for IUA prevention has been shown to be effective in this specific patient group.

Key Points: 
  • No device indicated for IUA prevention has been shown to be effective in this specific patient group.
  • PREG2 is an international, randomized clinical trial designed to measure Womed Leaf's effectiveness.
  • 160 women with severe or moderate IUA were randomly assigned to receive a Womed Leaf or not after adhesiolysis surgery.
  • "Womed Leaf, which is already registered in Europe and Brazil, will be marketed through commercial partners."

PanTheryx® Welcomes Menopause Specialist, Jaime Seeman, M.D., OB-GYN to its Scientific Advisory Board

Retrieved on: 
星期四, 三月 7, 2024
Health, Consumer, Women, Fitness & Nutrition, General Health, Vitamins, Supplements, Private practice, Woman, System, Obstetrics, Multimedia, RDN, University, American Nutrition Association, Nebraska Medicine, Skin, Gynaecology, Probiotic, Outline of health sciences, Menopause, Alternative medicine, Mid-City, Physical fitness, North American Menopause Society, Dietary supplement

and OB-GYN to its esteemed Scientific Advisory Board.

Key Points: 
  • and OB-GYN to its esteemed Scientific Advisory Board.
  • View the full release here: https://www.businesswire.com/news/home/20240307019894/en/
    "We are delighted to welcome Dr. Jaime Seeman as a new member of our Scientific Advisory Board.
  • "I am honored to join the respected group of experts on PanTheryx’s Scientific Advisory Board.
  • ; and Mia Syn, MS, RDN, on PanTheryx's Scientific Advisory Board, each committed to advancing the company's mission to bring cutting-edge research, and innovative products to consumers.

ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities

Retrieved on: 
星期二, 三月 5, 2024
Biotechnology, FDA, AIDS, Health, Training, Pharmaceutical, Other Education, Other Philanthropy, Philanthropy, Research, Infectious Diseases, Education, Science, Clinical Trials, Acquisition, Pre-exposure prophylaxis, Pfizer, Incidence, Shionogi, Woman, Medicine, Fungal infection, GSK, CROI, HIV Medicine, Notifiable disease, Emergency medicine, Dawn, Conference, Gynaecology, Mentorship, Preceptor, Patient, MPH, ViiV Healthcare, HIV, Obstetrics, American Academy, Pharmaceutical industry

Today, ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the American Academy of HIV Medicine (AAHIVM) jointly announced the launch of The Dr.

Key Points: 
  • Today, ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the American Academy of HIV Medicine (AAHIVM) jointly announced the launch of The Dr.
  • Dawn K. Smith HIV Prevention Clinical Fellowship.
  • The fellowship will provide comprehensive HIV training to non-infectious disease clinicians serving communities disproportionately affected by HIV.
  • Dawn K. Smith HIV Prevention Clinical Fellowship, experienced HIV clinicians will provide that training in priority populations and areas, with a special emphasis on pre-exposure prophylaxis (PrEP).”
    The Dr.

Equality Health Foundation and March of Dimes Host Healthy Mama Festival

Retrieved on: 
星期四, 三月 7, 2024
Greeting, Medicine, Person, Transport, Maternal death, Health education, Health care, Pregnancy, Health, Hypertension, Department of Health Services, Death, Organization, Mother, Infant, Black, Family, Obstetrics, Health equity, Food security, Mortality, Housing, Education, Nursing

PHOENIX, March 7, 2024 /PRNewswire-PRWeb/ -- Equality Health Foundation, in collaboration with the March of Dimes, the leading organization fighting for the health of moms and babies, and premier sponsor Mercy Care, is pleased to announce the inaugural Healthy Mama Festival and Diaper Bag Giveaway happening on Saturday, March 9 at the Pilgrim Rest Baptist Church in South Phoenix. This free event is dedicated to promoting health and well-being education for all mothers, soon-to-be mothers and their children.

Key Points: 
  • "The Healthy Mama Festival is an extension of Equality Health Foundation's commitment to supporting and empowering families with culturally informed health care and maternal health education during this transformative period."
  • Equality Health Foundation works to expand access to whole-person care, accelerate health education, and eliminate healthcare inequalities for all.
  • "As long-standing partners with both Equality Health Foundation and March of Dimes, Mercy Care is aligned with the mission of these two organizations and the objectives of the Healthy Mama Festival.
  • For more information on Equality Health Foundation and the festival, please visit equalityhealthfoundation.org/healthy-mama-festival-phoenix/ .

The Inner Circle acknowledges Hazem Kanaan, DO as a Pinnacle Lifetime Member

Retrieved on: 
星期三, 三月 6, 2024
Award, UHS, Woman, Inner circle, Multimedia, Education, Obesity, Kennesaw State University, Obstetrics, Kennesaw, Georgia, DSM-IV codes, Lower Rio Grande Valley, Health, University, Human, Mentorship, PCOS, Henry Ford Health, Organization, Patient, Family, Women's health, Knowledge, Politics, Obesity medicine, Nursing

EDINBURG, Texas, March 6, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Hazem Kanaan, DO is acknowledged as a Pinnacle Lifetime Member for his contributions as an Obstetrician-Gynecologist.

Key Points: 
  • EDINBURG, Texas, March 6, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Hazem Kanaan, DO is acknowledged as a Pinnacle Lifetime Member for his contributions as an Obstetrician-Gynecologist.
  • His impressive journey through education and medical practice is a testament to his unwavering commitment to women's health and reproductive care.
  • Dr. Kanaan embarked on his academic journey at Kennesaw State University, where he earned his undergraduate degree in Biochemistry with Cum-Laude Honors in 2005.
  • In his personal life, Dr. Kanaan acknowledges the profound impact of his family on his career, considering them a significant career accomplishment.

Hammes completes Silicon Valley Surgery Center in Campbell, California

Retrieved on: 
星期二, 二月 27, 2024
Urology, Senior, Physician, Silicon, General surgery, Gynaecology, Pain management, Operating, HCA Healthcare, Otorhinolaryngology, Hand, Podiatry, Gastroenterology, Obstetrics, Hospital

MILWAUKEE, Feb. 27, 2024 /PRNewswire-PRWeb/ -- Hammes, a nationally recognized leader in healthcare development, completed the development of a new ambulatory surgery center located at 2605 South Winchester Boulevard in Campbell, California. Silicon Valley Surgery Center is a joint venture between Surgery Ventures, powered by HCA Healthcare, and more than 50 multi-specialty physicians.

Key Points: 
  • Silicon Valley Surgery Center is a joint venture between Surgery Ventures, powered by HCA Healthcare, and more than 50 multi-specialty physicians.
  • We are proud to have supported the Silicon Valley Surgery Center surgeons and medical staff with a seamless transition from multiple locations to this new, conveniently located, state-of-the-art center.
  • The Silicon Valley Surgery Center team relocated from existing locations to the new, 24,000-square-foot, state-of-the-art surgery center at the end of 2023.
  • "We are proud to have supported the Silicon Valley Surgery Center surgeons and medical staff with a seamless transition from multiple locations to this new, conveniently located, state-of-the-art center," said Stephen Buckeridge, Senior Vice President of Hammes Partners.